Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway
Author:
Funder
Science and Technology Commission of Shanghai Municipality
Publisher
Elsevier BV
Subject
Pharmacology
Reference41 articles.
1. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver;Alonzi;Mol. Cell Biol.,2001
2. beta-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-kB signal pathways;Bao;Chem. Biol. Interact.,2021
3. Osteosarcoma of the Larynx: treatment outcomes and patterns of failure analysis;Bennion;Rare Tumors,2017
4. The anticancer properties of silibinin: its molecular mechanism and therapeutic effect in breast cancer;Binienda;Anti Cancer Agents Med. Chem.,2020
5. JAK2 inhibitors for myeloproliferative neoplasms: what is next?;Bose;Blood,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eurycomanone inhibits osteosarcoma growth and metastasis by suppressing GRP78 expression;Journal of Ethnopharmacology;2024-12
2. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells;Frontiers in Pharmacology;2024-02-14
3. Oleanolic acid inhibits colon cancer cell stemness and reverses chemoresistance by suppressing JAK2/STAT3 signaling pathway;BIOCELL;2024
4. MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway in Vivo and in Vitro;Technology in Cancer Research & Treatment;2024-01
5. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis;International Journal of Molecular Sciences;2023-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3